CORONAVIRUS INFECTION
Clinical trials for CORONAVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CORONAVIRUS INFECTION trials appear
Sign up with your email to follow new studies for CORONAVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control TerminatedThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Matched conditions: CORONAVIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Hydroxychloroquine trial for COVID-19 fizzles out
Disease control TerminatedThis early-phase study tested whether hydroxychloroquine, a drug used for malaria and autoimmune diseases, could reduce the amount of virus in adults with mild COVID-19 not needing oxygen. Only 8 people took part before the trial was stopped early. The study was too small to draw…
Matched conditions: CORONAVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC